M-end is a program about ending malaria and changing the lives of those whose families have suffered with it for many generations. It is about bringing healing to individuals, villages, and countries both spiritually and physically to create positive change no matter what their individual economic status. It is about mending both bodies and souls, so they can live healthy and productive lives. It is about working with governments, churches and clinicians to reduce the risk faced by millions of people dying of malaria every year, with the majority of those being young children. M-end is about restoring lives and ending a disease that has plagued mankind for over thousands of years. M-end is a not-for-profit organization that is about clinically eradicating malaria while introducing faith into the lives of those who are renewed to new health.
The origins of this program came out of the nonmedical efforts of a geologist who needed to travel to malaria infested areas. He and his team on occasion would contract malaria in places where medical treatment was unavailable. It was under these circumstances that the team found that the same treatment they were using to sanitize their water was effective in rapidly ending their malaria symptoms. The elements of this treatment were refined by Dr. Hesselink and then incorporated into the kits of clinicians who were doing medical mission work in Africa. Since the treatment components are compact and do not need refrigeration they are easy to take into the rural areas where populations are hit hardest by the risk of malaria and unclean drinking water.
In 2007, Physicians Susan Busse and Thomas Hesselink along with chemical engineer John Peterson began to work with this oral treatment on medical mission trips, originally calling the program the Malaria Initiative. The Malaria Initiative in 2011 was renamed M-END, giving it its own identity as a nonprofit organization dedicated to restoring lives and ending malaria. The next step of this program is to begin formal clinical trials this fall so it can be introduced into treatment protocols worldwide as an accepted treatment for malaria.
The treatment is administered orally to eradicate malaria from an individual’s blood stream. Costing less than five U.S. pennies per dose, the materials consist of two packets, one weighing 10 grams and the other 20 grams making the basic chemical mixture remarkably portable, fitting easily into a shirt pocket. This allows easy distribution and those two tiny packets can treat 200-400 people. (For complete scientific information and credentials of the founding directors, please turn to the organizational information section).